A European study discovered several markers in the blood of kidney transplant patients that could indicate whether a patient will reject a kidney and the amount of immunosuppressant drugs he or she will need. The finding could guide doctors in managing transplant patients and allow for a modification in the amount of drugs that patients have to take to prevent organ rejection, the researchers said.

Full Story:

Related Summaries